Stock IRME IR-MED INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News IR-Med Inc.

Equities

IRME

US46265R1032

Market Closed - OTC Markets
Other stock markets
 09:30:18 2024-05-30 EDT 		5-day change 1st Jan Change
1 USD +31.58% Intraday chart for IR-Med Inc. +66.67% -13.04%
05-22 IR-Med Inc.?s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel?s Hmo CI
05-13 IR-Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IR-MED’s PressureSafe™ Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Largest HMO
AQ
IR-Med Inc.?s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel?s Hmo
CI
IR-Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
CI
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
AQ
IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
IR-Med Inc. and I.R Med Ltd. Appoints Aharon Klein as Interim Chief Executive Officer
CI
IR-Med Inc. Announces Cessation of Tzur Di-Cori Pursuant as Chief Executive Officer
CI
IR-Med Inc. Announces Resignation of Inna Martin as Director
CI
IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries
AQ
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16
AQ
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe? Device at NPIAP 2024 Annual Conference on February 16
CI
IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine
AQ
IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue
AQ
IR-Med Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer
AQ
IR-MED Announces Executive Changes Effective as of October 15, 2023
CI
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
AQ
Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024
CI
IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IRME Stock
  4. News IR-Med Inc.